Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LLPH pseudogene 2 (LLPHP2) is a non-protein-coding segment of DNA highly similar to the LLPH gene but rendered inactive by mutations. Pseudogenes such as LLPHP2 are considered "gene relics": they are often formed by duplication or retrotransposition of functional genes, then lose ability to produce functional proteins due to accumulated mutations or regulatory sequence losses[5][6]. Although most pseudogenes are considered nonfunctional, extremely rare cases exist in which a pseudogene transcript may regulate its parent gene or function as a non-coding RNA, but there is no evidence that LLPHP2 displays such regulatory functions[4][5][6]. No disease associations, drug interactions, or diagnostic use have been described for LLPHP2. LLPHP2 should not be confused with the protein-coding gene LLPH (LLP homolog, long-term synaptic facilitation factor), which is expressed in neuronal cells and does have RNA binding activity[1]. Pseudogenes can occasionally interfere with molecular assays, such as PCR, due to sequence similarity with their parent genes, but are not therapeutic targets or biomarkers[5]. LLPHP2 is a nonfunctional pseudogene, not involved in drug targeting, disease biology, or clinical monitoring[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LLPH pseudogene 2 (LLPHP2).